[14C]EIK1001 clinical trials

An open-label mass balance study of [14C]EIK1001 in healthy male subjects

This study is looking into how the body handles a new cancer drug, EIK1001. We need healthy men to take a single dose to see how the body breaks it down and gets rid of it. This helps doctors create more effective cancer treatments for the future.